Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05623306 · ClinicalTrials.gov registry record · NA
SEEG-Guided DBS for OCD
A NA study of Obsessive - Compulsive Disorder, sponsored by Casey H. Halpern, M.D..
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT05623306: Recruiting NA study of Obsessive - Compulsive Disorder, sponsored by Casey H. Halpern, M.D..
NCT05623306 is a NA study of Obsessive - Compulsive Disorder that is actively recruiting participants, run by Casey H. Halpern, M.D.. The registered enrollment target is 10 participants, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05623306, a NA study of Obsessive - Compulsive Disorder, is actively recruiting participants, sponsored by Casey H. Halpern, M.D..
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open label stimulation for an additional 6 months. The study will be conducted in 3 stages: Stage 1 will consist of SEEG brain mapping and optimization of stimulation parameters. Stage 2 will consist of DBS surgery and further optimization of stimulation parameters. Stage 3 will be randomized, crossover treatment, followed by open label treatment.
Primary Outcome
Percentage of patients in which an OCD relevant network can be identified
Conditions Studied
Interventions
- DEVICE PMT Stereoencephalography (SEEG)
- DEVICE Vercise Genus™ Deep Brain Stimulation (DBS) System or Percept™ PC Neurostimulation System
Study Locations (2)
California
- Stanford University - Stanford
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-04-13 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What NCT05623306 shows while recruiting
NCT05623306 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 2,065-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 2 interventions - of which PMT Stereoencephalography (SEEG) is the first listed.
NCT05623306 reports a single indexed study location in California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05623306 about?
NCT05623306 is a clinical study titled "SEEG-Guided DBS for OCD". This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open label stimulation for an additional 6 months. The study will be conducted in 3 stages: Stage 1 will consist of SEEG brain mapping and optimization of sti...
What is the current status of trial NCT05623306?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-04-13. Estimated completion is 2027-01-01.
What conditions does trial NCT05623306 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.
What interventions are being tested in trial NCT05623306?
The interventions under investigation include: PMT Stereoencephalography (SEEG) (DEVICE), Vercise Genus™ Deep Brain Stimulation (DBS) System or Percept™ PC Neurostimulation System (DEVICE).
Who is sponsoring clinical trial NCT05623306?
This trial is sponsored by Casey H. Halpern, M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05623306 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05623306's enrollment target sits among peer trials
10 77th of 84 higher than 7 of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Interpretation Bias as a Mechanism of Treatment Response in OCD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI